Magnesium sulphate in management of severe pre-eclampsia and eclampsia

Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Nepal Health Research Council 2012-05, Vol.10 (21), p.113-117
Hauptverfasser: Dhakal, G, Subedi, M, Paudel, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 117
container_issue 21
container_start_page 113
container_title Journal of Nepal Health Research Council
container_volume 10
creator Dhakal, G
Subedi, M
Paudel, K
description Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the most effective and low cost medication. The objective of the study was to explore current situation of SPE/E management using MgSO4 in 10 health facilities of Mid Western Development Region. Descriptive and single group pre-test, post test study design was used for the study. Data were collected by reviewing records, taking interviews and through observation. Knowledge and skills of service provider was assessed and scored (0-100%) before and after the educational intervention. One year records indicate that 0.5% SPE/E cases were found in Dang Sub Regional Hospital and Pyuthan District Hospital; 0.4% in Bheri Zonal Hospital; 0.9% in Mehelkuna PHCC and 0.5% in Rajapur PHCC. In most of the hospitals, these cases were managed with MgSO4. During pre-testing none of the health facility was able to get standard score (80%) but in post test, 50% health facilities were able to get 80% or higher score. Establishing national standard and providing one-time training is not sufficient, it requires refresher onsite training for propermanagement of SPE/E on time to improve maternal and neonatal health.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1093535549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1093535549</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-bb82415aedca3d58ae3188369bbec19c016253833879f19e5a0230ff034fce5e3</originalsourceid><addsrcrecordid>eNo9j0FLxDAUhIMg7rLuX5AcvRT6-po2OcriqrDiRc_lNX1ZK002Nq3gv7fg6lyGgY9h5kKswRiTVQXUK7FN6SNfVAEqgCuxKjDHEutiLfbPdAyc-tnLNA_xnSaWfZCeAh3Zc5jkycnEXzyyjCNnbAfyMfUkKXTyP12LS0dD4u3ZN-Jtf_-6e8wOLw9Pu7tDFqGopqxtdVGCIu4sYac0MYLWWJm2ZQvG5lAVCjWiro0Dw4ryZapzy1pnWTFuxO1vbxxPnzOnqfF9sjwMFPg0pwZygwqVKs2C3pzRufXcNXHsPY3fzd93_AFNgVTT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1093535549</pqid></control><display><type>article</type><title>Magnesium sulphate in management of severe pre-eclampsia and eclampsia</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Dhakal, G ; Subedi, M ; Paudel, K</creator><creatorcontrib>Dhakal, G ; Subedi, M ; Paudel, K</creatorcontrib><description>Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the most effective and low cost medication. The objective of the study was to explore current situation of SPE/E management using MgSO4 in 10 health facilities of Mid Western Development Region. Descriptive and single group pre-test, post test study design was used for the study. Data were collected by reviewing records, taking interviews and through observation. Knowledge and skills of service provider was assessed and scored (0-100%) before and after the educational intervention. One year records indicate that 0.5% SPE/E cases were found in Dang Sub Regional Hospital and Pyuthan District Hospital; 0.4% in Bheri Zonal Hospital; 0.9% in Mehelkuna PHCC and 0.5% in Rajapur PHCC. In most of the hospitals, these cases were managed with MgSO4. During pre-testing none of the health facility was able to get standard score (80%) but in post test, 50% health facilities were able to get 80% or higher score. Establishing national standard and providing one-time training is not sufficient, it requires refresher onsite training for propermanagement of SPE/E on time to improve maternal and neonatal health.</description><identifier>EISSN: 1999-6217</identifier><identifier>PMID: 23034372</identifier><language>eng</language><publisher>Nepal</publisher><subject>Calcium Channel Blockers - supply &amp; distribution ; Calcium Channel Blockers - therapeutic use ; Clinical Competence ; Eclampsia - prevention &amp; control ; Educational Status ; Female ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility ; Health Services Needs and Demand ; Humans ; Magnesium Sulfate - supply &amp; distribution ; Magnesium Sulfate - therapeutic use ; Maternal Mortality ; Nepal ; Pre-Eclampsia - prevention &amp; control ; Pregnancy ; Quality Improvement ; Severity of Illness Index</subject><ispartof>Journal of Nepal Health Research Council, 2012-05, Vol.10 (21), p.113-117</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23034372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dhakal, G</creatorcontrib><creatorcontrib>Subedi, M</creatorcontrib><creatorcontrib>Paudel, K</creatorcontrib><title>Magnesium sulphate in management of severe pre-eclampsia and eclampsia</title><title>Journal of Nepal Health Research Council</title><addtitle>J Nepal Health Res Counc</addtitle><description>Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the most effective and low cost medication. The objective of the study was to explore current situation of SPE/E management using MgSO4 in 10 health facilities of Mid Western Development Region. Descriptive and single group pre-test, post test study design was used for the study. Data were collected by reviewing records, taking interviews and through observation. Knowledge and skills of service provider was assessed and scored (0-100%) before and after the educational intervention. One year records indicate that 0.5% SPE/E cases were found in Dang Sub Regional Hospital and Pyuthan District Hospital; 0.4% in Bheri Zonal Hospital; 0.9% in Mehelkuna PHCC and 0.5% in Rajapur PHCC. In most of the hospitals, these cases were managed with MgSO4. During pre-testing none of the health facility was able to get standard score (80%) but in post test, 50% health facilities were able to get 80% or higher score. Establishing national standard and providing one-time training is not sufficient, it requires refresher onsite training for propermanagement of SPE/E on time to improve maternal and neonatal health.</description><subject>Calcium Channel Blockers - supply &amp; distribution</subject><subject>Calcium Channel Blockers - therapeutic use</subject><subject>Clinical Competence</subject><subject>Eclampsia - prevention &amp; control</subject><subject>Educational Status</subject><subject>Female</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Health Services Accessibility</subject><subject>Health Services Needs and Demand</subject><subject>Humans</subject><subject>Magnesium Sulfate - supply &amp; distribution</subject><subject>Magnesium Sulfate - therapeutic use</subject><subject>Maternal Mortality</subject><subject>Nepal</subject><subject>Pre-Eclampsia - prevention &amp; control</subject><subject>Pregnancy</subject><subject>Quality Improvement</subject><subject>Severity of Illness Index</subject><issn>1999-6217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j0FLxDAUhIMg7rLuX5AcvRT6-po2OcriqrDiRc_lNX1ZK002Nq3gv7fg6lyGgY9h5kKswRiTVQXUK7FN6SNfVAEqgCuxKjDHEutiLfbPdAyc-tnLNA_xnSaWfZCeAh3Zc5jkycnEXzyyjCNnbAfyMfUkKXTyP12LS0dD4u3ZN-Jtf_-6e8wOLw9Pu7tDFqGopqxtdVGCIu4sYac0MYLWWJm2ZQvG5lAVCjWiro0Dw4ryZapzy1pnWTFuxO1vbxxPnzOnqfF9sjwMFPg0pwZygwqVKs2C3pzRufXcNXHsPY3fzd93_AFNgVTT</recordid><startdate>201205</startdate><enddate>201205</enddate><creator>Dhakal, G</creator><creator>Subedi, M</creator><creator>Paudel, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201205</creationdate><title>Magnesium sulphate in management of severe pre-eclampsia and eclampsia</title><author>Dhakal, G ; Subedi, M ; Paudel, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-bb82415aedca3d58ae3188369bbec19c016253833879f19e5a0230ff034fce5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Calcium Channel Blockers - supply &amp; distribution</topic><topic>Calcium Channel Blockers - therapeutic use</topic><topic>Clinical Competence</topic><topic>Eclampsia - prevention &amp; control</topic><topic>Educational Status</topic><topic>Female</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Health Services Accessibility</topic><topic>Health Services Needs and Demand</topic><topic>Humans</topic><topic>Magnesium Sulfate - supply &amp; distribution</topic><topic>Magnesium Sulfate - therapeutic use</topic><topic>Maternal Mortality</topic><topic>Nepal</topic><topic>Pre-Eclampsia - prevention &amp; control</topic><topic>Pregnancy</topic><topic>Quality Improvement</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dhakal, G</creatorcontrib><creatorcontrib>Subedi, M</creatorcontrib><creatorcontrib>Paudel, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Nepal Health Research Council</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dhakal, G</au><au>Subedi, M</au><au>Paudel, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnesium sulphate in management of severe pre-eclampsia and eclampsia</atitle><jtitle>Journal of Nepal Health Research Council</jtitle><addtitle>J Nepal Health Res Counc</addtitle><date>2012-05</date><risdate>2012</risdate><volume>10</volume><issue>21</issue><spage>113</spage><epage>117</epage><pages>113-117</pages><eissn>1999-6217</eissn><abstract>Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the most effective and low cost medication. The objective of the study was to explore current situation of SPE/E management using MgSO4 in 10 health facilities of Mid Western Development Region. Descriptive and single group pre-test, post test study design was used for the study. Data were collected by reviewing records, taking interviews and through observation. Knowledge and skills of service provider was assessed and scored (0-100%) before and after the educational intervention. One year records indicate that 0.5% SPE/E cases were found in Dang Sub Regional Hospital and Pyuthan District Hospital; 0.4% in Bheri Zonal Hospital; 0.9% in Mehelkuna PHCC and 0.5% in Rajapur PHCC. In most of the hospitals, these cases were managed with MgSO4. During pre-testing none of the health facility was able to get standard score (80%) but in post test, 50% health facilities were able to get 80% or higher score. Establishing national standard and providing one-time training is not sufficient, it requires refresher onsite training for propermanagement of SPE/E on time to improve maternal and neonatal health.</abstract><cop>Nepal</cop><pmid>23034372</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1999-6217
ispartof Journal of Nepal Health Research Council, 2012-05, Vol.10 (21), p.113-117
issn 1999-6217
language eng
recordid cdi_proquest_miscellaneous_1093535549
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Calcium Channel Blockers - supply & distribution
Calcium Channel Blockers - therapeutic use
Clinical Competence
Eclampsia - prevention & control
Educational Status
Female
Health Knowledge, Attitudes, Practice
Health Services Accessibility
Health Services Needs and Demand
Humans
Magnesium Sulfate - supply & distribution
Magnesium Sulfate - therapeutic use
Maternal Mortality
Nepal
Pre-Eclampsia - prevention & control
Pregnancy
Quality Improvement
Severity of Illness Index
title Magnesium sulphate in management of severe pre-eclampsia and eclampsia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A15%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnesium%20sulphate%20in%20management%20of%20severe%20pre-eclampsia%20and%20eclampsia&rft.jtitle=Journal%20of%20Nepal%20Health%20Research%20Council&rft.au=Dhakal,%20G&rft.date=2012-05&rft.volume=10&rft.issue=21&rft.spage=113&rft.epage=117&rft.pages=113-117&rft.eissn=1999-6217&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1093535549%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1093535549&rft_id=info:pmid/23034372&rfr_iscdi=true